Tirzepatide Dosage Chart and Schedule
FDA-approved
Weekly GIP and GLP-1 agonist (Mounjaro, Zepbound). Label: 2.5 mg start, +2.5 mg every 4 weeks, max 15 mg.
Also called: Mounjaro, Zepbound, LY3298176
Regulatory status (US)
FDA-approved as Mounjaro (type 2 diabetes, 2022) and Zepbound (chronic weight management, 2023; obstructive sleep apnea, 2024). The FDA declared the tirzepatide shortage over in December 2024, which ended the temporary allowance for mass compounding.
What it is
A once-weekly injectable peptide that activates the GIP and GLP-1 receptors.
Label dose escalation (Mounjaro and Zepbound)
| Weeks | Weekly dose | Note |
|---|---|---|
| 1-4 | 2.5 mg | Starting dose only, not a maintenance dose |
| 5-8 | 5 mg | Possible maintenance dose |
| 9-12 | 7.5 mg | Increase in 2.5 mg steps after at least 4 weeks |
| 13-16 | 10 mg | Maintenance dose |
| 17-20 | 12.5 mg | |
| 21+ | 15 mg | Maximum dose |
From the Mounjaro and Zepbound prescribing information. A missed dose can be taken within 4 days (96 hours).
Tirzepatide reconstitution calculator
Enter your vial and your prescribed dose to see the units on a U-100 syringe. A units chart for every dose step is on the Tirzepatide reconstitution calculator page.
What human studies show
- Approved on the basis of the SURPASS (diabetes) and SURMOUNT (weight) phase 3 programs; dosing below is from the current label.
Storage
- Branded pens and vials: refrigerate at 2-8 °C. Single-dose pens or vials may be kept unrefrigerated (up to 30 °C) for up to 21 days total.
- Multi-dose KwikPen or vial after first use: discard after 30 days or 4 doses, whichever comes first.
- Branded single-dose pens and vials come ready to use (2.5 to 15 mg per 0.5 mL) and are not reconstituted. Reconstitution math applies to powder vials.
Safety
- Boxed warning: risk of thyroid C-cell tumors. Do not use with a personal or family history of medullary thyroid carcinoma or MEN 2.
- Warnings include pancreatitis, gallbladder disease, low blood sugar with insulin or sulfonylureas, kidney injury from dehydration, severe GI reactions and aspiration under anesthesia.
- Do not combine with other GLP-1 drugs.
Compare
- Retatrutide vs Tirzepatide
- Tirzepatide vs Semaglutide
- Orforglipron vs Tirzepatide
- CagriSema vs Tirzepatide
Questions
- Is Tirzepatide FDA-approved?
- FDA-approved as Mounjaro (type 2 diabetes, 2022) and Zepbound (chronic weight management, 2023; obstructive sleep apnea, 2024). The FDA declared the tirzepatide shortage over in December 2024, which ended the temporary allowance for mass compounding.
- What dose of Tirzepatide has been studied?
- 1-4: 2.5 mg: Starting dose only, not a maintenance dose; 5-8: 5 mg: Possible maintenance dose; 9-12: 7.5 mg: Increase in 2.5 mg steps after at least 4 weeks; 13-16: 10 mg: Maintenance dose; 17-20: 12.5 mg; 21+: 15 mg: Maximum dose. From the Mounjaro and Zepbound prescribing information. A missed dose can be taken within 4 days (96 hours).
- How many units is my Tirzepatide dose?
- Divide the mg in the vial by the mL of bacteriostatic water to get mg/mL, divide your dose in mg by that, and multiply by 100 for units on a U-100 syringe. The calculator on this page does it and draws the syringe.
Related
Weekly GLP-1 agonist (Ozempic, Wegovy). Wegovy label: 0.25 mg start, up to 2.4 mg, or 7.2 mg (HD).
Orforglipron (Foundayo)Daily GLP-1 pill from Lilly (Foundayo), approved April 2026. Not a peptide and never reconstituted.
TesamorelinGHRH analogue (Egrifta) approved for HIV-associated abdominal fat. Egrifta WR: 1.28 mg daily.
Elamipretide (SS-31)Mitochondria-targeted peptide (Forzinity), approved 2025 only for Barth syndrome. Label: 40 mg daily.
Sources
- Mounjaro (tirzepatide) US prescribing information, Eli Lilly
- Zepbound (tirzepatide) US prescribing information, Eli Lilly
- FDA approves new medication for chronic weight management (Zepbound, Nov 2023)
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss
- FDA 510(k) K212499: BD insulin syringes for U-100 insulin
Last checked 2026-11-16. How we pick and check sources: methodology.